U.S. federal trademark · Serial No. 74724086
providing medical treatment to increase and to potentiate a patient's effector cells to enhance immune capacity against lung cancer, metastatic to the lung or refractory advanced malignancies, cancer, HIV infection, AIDS or other disease pathogens and/or prepare the immune system for lymphokine, cytokine or other biological response modifier administration
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.